INNATEvertnoir.png
INNATE PHARMA ANNONCE LA PUBLICATION DANS NATURE DES RESULTATS DE L’ETUDE TRANSLATIONNELLE EXPLORE COVID-19
July 29, 2020 05:30 ET | INNATE PHARMA
Les données suggèrent que le ciblage de la voie C5a-C5aR1 pourrait limiter la réponse inflammatoire sévère Innate Pharma SA (Euronext Paris : IPH – ISIN : FR0010331421 ; Nasdaq : IPHA) (« Innate » ou...
INNATEvertnoir.png
INNATE PHARMA ANNOUNCES PUBLICATION OF EXPLORE COVID-19 TRANSLATIONAL STUDY FINDINGS IN NATURE
July 29, 2020 05:30 ET | INNATE PHARMA
New research suggests targeting C5a-C5aR1 axis could limit severe inflammatory response Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today...
INNATEvertnoir.png
Innate Pharma Announces Publication of EXPLORE COVID-19 Translational Study Findings in Nature
July 29, 2020 05:30 ET | INNATE PHARMA
MARSEILLE, France, July 29, 2020 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced the publication of a Nature...